Evidence map›Paper›PMID 38993479›Full record

ArticleFrontiers in genetics2024

Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study.

Yingtong Wu, Yinggang Che, Yong Zhang, Yanlu Xiong, Chen Shu, Jun Jiang, Gaozhi Li, Lin Guo, Tianyun Qiao, Shuwen Li and 10 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Yingtong Wu *Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Yinggang Che *Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Yong ZhangDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Yanlu XiongDepartment of Thoracic Surgery, Tangdu Hospital, Air-Force Medical University, Xi'an, China.
Chen ShuDepartment of Thoracic Surgery, Tangdu Hospital, Air-Force Medical University, Xi'an, China.
Jun JiangDepartment of Health Service, Air-Force Medical University, Xi'an, China.
Gaozhi Li94498th Unit of the People's Liberation Army of China, Nanyang, China.
Lin GuoDepartment of Obstetrics and Gynecology, Tangdu Hospital, Air-Force Medical University, Xi'an, China.
Tianyun QiaoDepartment of Thoracic Surgery, Tangdu Hospital, Air-Force Medical University, Xi'an, China.
Shuwen LiFirst Sanatorium, Air Force Healthcare Center for Special Services, Hangzhou, China.
Ou LiFirst Sanatorium, Air Force Healthcare Center for Special Services, Hangzhou, China.
Ning ChangDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Xinxin ZhangCollege of Pulmonary and Critical Care Medicine, the 8th Medical Centre of Chinese PLA General Hospital, Beijing, China.
Minzhe ZhangDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Dan QiuDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Hangtian XiDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Jinggeng LiDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Xiangxiang ChenDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.
Mingxiang YeDepartment of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Jian ZhangDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Air-Force Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Observational investigations have examined the impact of glucosamine use on the risk of cancer and non-neoplastic diseases. However, the findings from these studies face limitations arising from confounding variables, reverse causation, and conflicting reports. Consequently, the establishment of a causal relationship between habitual glucosamine consumption and the risk of cancer and non-neoplastic diseases necessitates further investigation. Methods: For Mendelian randomization (MR) investigation, we opted to employ single-nucleotide polymorphisms (SNPs) as instruments that exhibit robust associations with habitual glucosamine consumption. We obtained the corresponding effect estimates of these SNPs on the risk of cancer and non-neoplastic diseases by extracting summary data for genetic instruments linked to 49 varied cancer types amounting to 378,284 cases and 533,969 controls, as well as 20 non-neoplastic diseases encompassing 292,270 cases and 842,829 controls. Apart from the primary analysis utilizing inverse-variance weighted MR, we conducted two supplementary approaches to account for potential pleiotropy (MR-Egger and weighted median) and assessed their respective MR estimates. Furthermore, the results of the leave-one-out analysis revealed that there were no outlying instruments. Results: Our results suggest divergence from accepted biological understanding, suggesting that genetically predicted glucosamine utilization may be linked to an increased vulnerability to specific illnesses, as evidenced by increased odds ratios and confidence intervals (95% CI) for diseases, such as malignant neoplasm of the eye and adnexa (2.47 [1.34-4.55]), benign neoplasm of the liver/bile ducts (2.12 [1.32-3.43]), benign neoplasm of the larynx (2.01 [1.36-2.96]), melanoma (1.74 [1.17-2.59]), follicular lymphoma (1.50 [1.06-2.11]), autoimmune thyroiditis (2.47 [1.49-4.08]), and autoimmune hyperthyroidism (1.93 [1.17-3.18]). In contrast to prior observational research, our genetic investigations demonstrate a positive correlation between habitual glucosamine consumption and an elevated risk of sigmoid colon cancer, lung adenocarcinoma, and benign neoplasm of the thyroid gland. Conclusion: Casting doubt on the purported purely beneficial association between glucosamine ingestion and prevention of neoplastic and non-neoplastic diseases, habitual glucosamine ingestion exhibits dichotomous effects on disease outcomes. Endorsing the habitual consumption of glucosamine as a preventative measure against neoplastic and non-neoplastic diseases cannot be supported.

Indexed as

cancer riskcausalityglucosamineMendelian randomizationsingle-nucleotide polymorphisms

Identifiers

PMID38993479
PMCPMC11236616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.